In November 2023, the Company entered into a lease agreement for lab space. In June 2024, the agreement was amended to expand the space and extend the lease term through November 2026, with the option to extend for one year. In January 2025, the agreement was amended to further expand the space. As of June 30, 2025, the remaining lease term was 1.4 years and the weighted average incremental borrowing rate used to determine the operating lease liability was 9.1%.

In September 2024, the Company entered into a lease agreement for office space. The lease term is five years with two one-year options to extend. As of June 30, 2025, the remaining lease term was 4.3 years and the incremental borrowing rate used to determine the operating lease liability was 6.0%.

As of June 30, 2025, total current and non-current operating lease liabilities were $4.0 million and $6.8 million, respectively. The Company incurred lease expense of $1.1 million and $2.2 million for the three and six months ended June 30, 2025, respectively. The Company incurred lease expense of $0.4 million and $0.7 million for the three and six months ended June 30, 2024, respectively.